200 related articles for article (PubMed ID: 11800507)
21. Efficacy and safety of zolpidem extended release in elderly primary insomnia patients.
Walsh JK; Soubrane C; Roth T
Am J Geriatr Psychiatry; 2008 Jan; 16(1):44-57. PubMed ID: 18165461
[TBL] [Abstract][Full Text] [Related]
22. Zolpidem in the treatment of transient insomnia: a double-blind, randomized comparison with placebo.
Roth T; Roehrs T; Vogel G
Sleep; 1995 May; 18(4):246-51. PubMed ID: 7618022
[TBL] [Abstract][Full Text] [Related]
23. Zolpidem extended-release improves sleep and next-day symptoms in comorbid insomnia and generalized anxiety disorder.
Fava M; Asnis GM; Shrivastava R; Lydiard B; Bastani B; Sheehan D; Roth T
J Clin Psychopharmacol; 2009 Jun; 29(3):222-30. PubMed ID: 19440075
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of eight months of nightly zolpidem: a prospective placebo-controlled study.
Randall S; Roehrs TA; Roth T
Sleep; 2012 Nov; 35(11):1551-7. PubMed ID: 23115404
[TBL] [Abstract][Full Text] [Related]
25. Multicenter, double-blind, controlled comparison of zolpidem and triazolam in elderly patients with insomnia.
Roger M; Attali P; Coquelin JP
Clin Ther; 1993; 15(1):127-36. PubMed ID: 8458042
[TBL] [Abstract][Full Text] [Related]
26. Zolpidem extended-release.
Moen MD; Plosker GL
CNS Drugs; 2006; 20(5):419-26; discussion 427-8. PubMed ID: 16696581
[TBL] [Abstract][Full Text] [Related]
27. Gender influences on efficacy and safety of sublingual zolpidem tartrate for middle-of-the-night awakening in insomnia.
Roth T; Steinberg F; Singh NN; Moline M
Hum Psychopharmacol; 2014 Jan; 29(1):25-30. PubMed ID: 24424704
[TBL] [Abstract][Full Text] [Related]
28. Sleep latency is shortened during 4 weeks of treatment with zaleplon, a novel nonbenzodiazepine hypnotic. Zaleplon Clinical Study Group.
Elie R; Rüther E; Farr I; Emilien G; Salinas E
J Clin Psychiatry; 1999 Aug; 60(8):536-44. PubMed ID: 10485636
[TBL] [Abstract][Full Text] [Related]
29. [Efficacy and safety of modified release zolpidem in patients with chronic insomnia].
Jiménez-Genchi A;
Rev Med Inst Mex Seguro Soc; 2012; 50(5):529-36. PubMed ID: 23282267
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and Safety of Doxepin 1 mg and 3 mg in a 12-week Sleep Laboratory and Outpatient Trial of Elderly Subjects with Chronic Primary Insomnia.
Krystal AD; Durrence HH; Scharf M; Jochelson P; Rogowski R; Ludington E; Roth T
Sleep; 2010 Nov; 33(11):1553-61. PubMed ID: 21102997
[TBL] [Abstract][Full Text] [Related]
31. Safety and tolerance of zolpidem in the treatment of disturbed sleep: a post-marketing surveillance of 16944 cases.
Hajak G; Bandelow B
Int Clin Psychopharmacol; 1998 Jul; 13(4):157-67. PubMed ID: 9727726
[TBL] [Abstract][Full Text] [Related]
32. Randomized, double blind trial of zolpidem 10 mg versus triazolam 0.25 mg for treatment of insomnia in general practice.
Rosenberg J; Ahlstrøm F
Scand J Prim Health Care; 1994 Jun; 12(2):88-92. PubMed ID: 7973199
[TBL] [Abstract][Full Text] [Related]
33. Preference of insomniac patients between a single dose of zolpidem 10 mg versus zaleplon 10 mg.
Allain H; Bentué-Ferrer D; Breton SL; Polard E; Gandon JM
Hum Psychopharmacol; 2003 Jul; 18(5):369-74. PubMed ID: 12858323
[TBL] [Abstract][Full Text] [Related]
34. A double-blind, comparative study of zolpidem and placebo in the treatment of insomnia in elderly psychiatric in-patients.
Shaw SH; Curson H; Coquelin JP
J Int Med Res; 1992 Apr; 20(2):150-61. PubMed ID: 1521671
[TBL] [Abstract][Full Text] [Related]
35. [Treatment of insomnia related to depressive disorders. Effects of zolpidem versus flunitrazepam administration and withdrawal evaluated in a double-blind study].
Guazzelli M; Ciapparelli A; Balsamo EL; Gemignani A; Sarteschi P
Minerva Psichiatr; 1993 Sep; 34(3):193-203. PubMed ID: 8302193
[TBL] [Abstract][Full Text] [Related]
36. Polysomnographic study of intermittent zolpidem treatment in primary sleep maintenance insomnia.
Parrino L; Smerieri A; Giglia F; Milioli G; De Paolis F; Terzano MG
Clin Neuropharmacol; 2008; 31(1):40-50. PubMed ID: 18303490
[TBL] [Abstract][Full Text] [Related]
37. Sleep in patients with chronic primary insomnia during long-term zolpidem administration and after its withdrawal.
Monti JM; Monti D; Estévez F; Giusti M
Int Clin Psychopharmacol; 1996 Dec; 11(4):255-63. PubMed ID: 9031992
[TBL] [Abstract][Full Text] [Related]
38. A 2-week efficacy and safety study of gaboxadol and zolpidem using electronic diaries in primary insomnia outpatients.
Hajak G; Hedner J; Eglin M; Loft H; Stórustovu SI; Lütolf S; Lundahl J;
Sleep Med; 2009 Aug; 10(7):705-12. PubMed ID: 19346160
[TBL] [Abstract][Full Text] [Related]
39. Pilot controlled double-blind study of the hypnotic effects of zolpidem in patients with chronic 'learned' insomnia: psychometric and polysomnographic evaluation.
Herrmann WM; Kubicki ST; Boden S; Eich FX; Attali P; Coquelin JP
J Int Med Res; 1993; 21(6):306-22. PubMed ID: 8143886
[TBL] [Abstract][Full Text] [Related]
40. A new sublingual formulation of zolpidem for the treatment of sleep-onset insomnia.
Staner L; Danjou P; Luthringer R
Expert Rev Neurother; 2012 Feb; 12(2):141-53. PubMed ID: 22288669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]